These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11207233)

  • 21. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA; Mourad L; ter Haar J; Egberts AC
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 23. Defective alleles may not have contributed to adverse effects.
    Stiskal JA
    Ther Drug Monit; 2006 Feb; 28(1):142; author reply 143. PubMed ID: 16418712
    [No Abstract]   [Full Text] [Related]  

  • 24. Neonatal adverse reactions after in utero exposure to selective serotonin reuptake inhibitors: still controversial.
    Beaulac-Baillargeon L; Boucher N
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):855-6; author reply 856. PubMed ID: 16894088
    [No Abstract]   [Full Text] [Related]  

  • 25. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
    Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
    J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nocturnal enuresis after paroxetine abrupt discontinuation: a case report.
    Polimeni G; Grugno R; Cordici F; Vitetta A; Caputi AP; Bramanti P
    J Clin Psychopharmacol; 2008 Oct; 28(5):589-91. PubMed ID: 18794668
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serotonergic syndrome. Serotonergic syndrome caused by paroxetine].
    Hilberg T; Mørland J
    Tidsskr Nor Laegeforen; 1999 Apr; 119(11):1646-7. PubMed ID: 10385811
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin syndrome: case report and review of the literature.
    Weiner AL; Tilden FF; McKay CA
    Conn Med; 1997 Nov; 61(11):717-21. PubMed ID: 9419960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paroxetine and galactorrhea.
    Bonin B; Vandel P; Sechter D; Bizouard P
    Pharmacopsychiatry; 1997 Jul; 30(4):133-4. PubMed ID: 9271780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine-induced SIADH.
    Ayonrinde OT; Reutens SG; Sanfilippo FM
    Med J Aust; 1995 Oct; 163(7):390. PubMed ID: 7565274
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
    Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF
    Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal convulsions secondary to paroxetine withdrawal.
    Ahmed M; Parameshwaran A; Swamy P
    J Pak Med Assoc; 2007 Mar; 57(3):162. PubMed ID: 17432029
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serotonin syndrome as a result of concomitant use of paroxetine and sumatriptan].
    Hendrix Y; van Zagten MS
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):888-90. PubMed ID: 15868995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Paroxetine (paxil): use in clinical practice].
    Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
    Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxic effects of nefazodone.
    Peak DA
    Ann Emerg Med; 1997 Oct; 30(4):551. PubMed ID: 9326874
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combination of serotonergic agents resulted in severe adverse effects].
    Jägestedt M; von Bahr C
    Lakartidningen; 2004 Apr; 101(18):1618-9. PubMed ID: 15185539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syndrome of inappropriate secretion of antidiuretic hormone induced by paroxetine.
    Monmany J; Vázquez G; Rodríguez J; Domingo P
    Arch Intern Med; 1999 Sep; 159(17):2089-90. PubMed ID: 10510997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.